173 related articles for article (PubMed ID: 35044085)
1. Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG).
Hires M; Jane E; Kalavska K; Chovanec M; Mego M; Kasak P; Bertok T; Tkac J
Cancer Med; 2022 Feb; 11(4):968-982. PubMed ID: 35044085
[TBL] [Abstract][Full Text] [Related]
2. Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance.
Kelly LS; Birken S; Puett D
Mol Cell Endocrinol; 2007 Jan; 260-262():33-9. PubMed ID: 17081681
[TBL] [Abstract][Full Text] [Related]
3. Glycan Analysis as Biomarkers for Testicular Cancer.
Hires M; Jane E; Mego M; Chovanec M; Kasak P; Tkac J
Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31652641
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
Sakuramoto T; Kihara K; Kawai T
Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation on differential quantitation of human chorionic gonadotropin in testicular cancer].
Nakamura K; Deguchi N; Nakanoma T; Hagiwara M; Tazaki H; Hata J
Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):408-13. PubMed ID: 1694252
[TBL] [Abstract][Full Text] [Related]
7. Expression of human chorionic gonadotropin in testicular germ cell tumors.
Lempiäinen A; Sankila A; Hotakainen K; Haglund C; Blomqvist C; Stenman UH
Urol Oncol; 2014 Jul; 32(5):727-34. PubMed ID: 24502963
[TBL] [Abstract][Full Text] [Related]
8. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism in men with germ cell tumors and high levels of beta-human chorionic gonadotropin.
Giralt SA; Dexeus F; Amato R; Sella A; Logothetis C
Cancer; 1992 Mar; 69(5):1286-90. PubMed ID: 1371235
[TBL] [Abstract][Full Text] [Related]
11. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Concanavalin A-based lectin sorbents for the extraction of the human chorionic gonadotropin glycoforms prior to analysis by nano liquid chromatography-high resolution mass spectrometry.
Goumenou A; Chendo C; Combès A; Fournier T; Pichon V; Delaunay N
J Pharm Biomed Anal; 2024 May; 242():116022. PubMed ID: 38354538
[TBL] [Abstract][Full Text] [Related]
13. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.
Mann K; Karl HJ
Cancer; 1983 Aug; 52(4):654-60. PubMed ID: 6305481
[TBL] [Abstract][Full Text] [Related]
15. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of cisplatin-resistant testicular cancer cell lines established by two methods].
Li B; Dong S; Fan Z; Wu X; Wu J; Tong X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1755-9. PubMed ID: 26714911
[TBL] [Abstract][Full Text] [Related]
17. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry.
Fichtner A; Bohnenberger H; Elakad O; Richter A; Lenz C; Oing C; Ströbel P; Kueffer S; Nettersheim D; Bremmer F
World J Urol; 2022 Feb; 40(2):373-383. PubMed ID: 35084545
[TBL] [Abstract][Full Text] [Related]
19. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
20. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Price P; Hogan SJ; Bliss JM; Horwich A
Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
